Biogen Receives Clearance to Build New R&D Facility in Cambridge
June 23, 1999 09:19 AM
CAMBRIDGE, Mass., June 23 /PRNewswire/ -- Biogen, Inc. (BGEN) today announced that the Cambridge Planning Board has granted the Company's IPOP (Interim Planning Overlay Permit) application to construct a 210,000 square foot building intended for research and development office use. Biogen's IPOP application is the first such petition to be granted by the Cambridge Planning Board. The new six-story building will be located at 15 Cambridge Center and will accommodate approximately 400 new employees.
Jim Vincent, Biogen's Chairman and Chief Executive Officer, said, "Biogen's planned construction of a new building in Cambridge Center is indicative of the Company's rapid growth and of its commitment to expand its presence in the city of Cambridge."
Founded in 1978, Biogen currently employs 1,200 people worldwide, 800 of whom are located in the Company's five existing Cambridge Center facilities. The company also maintains a manufacturing plant in Research Triangle Park, North Carolina, and country offices in Canada, France, the United Kingdom, Germany, and The Netherlands. |
